Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation
Organic cation transporters (OCT), organic anion transporting polypeptides (OATP) and
organic anion transporters (OAT) from the solute carrier (SLC) family play an essential role …
organic anion transporters (OAT) from the solute carrier (SLC) family play an essential role …
Pharmacogenomic studies of current antidiabetic agents and potential new drug targets for precision medicine of diabetes
Z Zeng, SY Huang, T Sun - Diabetes Therapy, 2020 - Springer
Diabetes is a major threat to people's health and has become a burden worldwide. Current
drugs for diabetes have limitations, such as different drug responses among individuals …
drugs for diabetes have limitations, such as different drug responses among individuals …
Potential impact of microRNA gene polymorphisms in the pathogenesis of diabetes and atherosclerotic cardiovascular disease
MicroRNAs (miRNAs) are endogenous, small (18–23 nucleotides), non-coding RNA
molecules. They regulate the posttranscriptional expression of their target genes. MiRNAs …
molecules. They regulate the posttranscriptional expression of their target genes. MiRNAs …
The impact of genetic polymorphisms in organic cation transporters on renal drug disposition
Z Zazuli, NJCB Duin, K Jansen, SJH Vijverberg… - International journal of …, 2020 - mdpi.com
A considerable number of drugs and/or their metabolites are excreted by the kidneys
through glomerular filtration and active renal tubule secretion via transporter proteins …
through glomerular filtration and active renal tubule secretion via transporter proteins …
Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta …
A Peng, C Gong, Y Xu, X Liang, X Chen… - Frontiers in Public …, 2023 - frontiersin.org
Background Variants in organic cation transporter (OCT) genes play a crucial role in
metformin pharmacokinetics and are critical for diabetes treatment. However, studies …
metformin pharmacokinetics and are critical for diabetes treatment. However, studies …
[HTML][HTML] Metformin and insulin-resistant related diseases: Emphasis on the role of microRNAs
N Alimoradi, N Firouzabadi, R Fatehi - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Metformin is one of the most prescribed drugs in type II diabetes (T2DM) which has recently
found new applications in the prevention and treatment of various illnesses, from metabolic …
found new applications in the prevention and treatment of various illnesses, from metabolic …
Circulating microRNAs signature for predicting response to GLP1-RA therapy in type 2 diabetic patients: a pilot study
Type 2 diabetes (T2D) represents one of the major health issues of this century. Despite the
availability of an increasing number of anti-hyperglycemic drugs, a significant proportion of …
availability of an increasing number of anti-hyperglycemic drugs, a significant proportion of …
Glucose metabolism-related gene polymorphisms as the risk predictors of type 2 diabetes
C Li, Y Yang, X Liu, Z Li, H Liu, Q Tan - Diabetology & Metabolic …, 2020 - Springer
Type 2 diabetes mellitus (T2DM) is a complex polygenic metabolic disease characterized by
elevated blood glucose. Multiple environmental and genetic factors can increase the risk of …
elevated blood glucose. Multiple environmental and genetic factors can increase the risk of …
The influence of SLC22A3 rs543159 and rs1317652 genetic variants on metformin therapeutic efficacy in newly diagnosed patients with type 2 diabetes mellitus: 25 …
Background and aims Among anti-diabetic medications, metformin has been proven to be
the preferred initial pharmacologic agent for type 2 diabetes mellitus (T2DM) treatment …
the preferred initial pharmacologic agent for type 2 diabetes mellitus (T2DM) treatment …
Identification of prognostic organic cation and anion transporters in different cancer entities by in silico analysis
B Edemir - International journal of molecular sciences, 2020 - mdpi.com
The information derived from next generation sequencing technology allows the
identification of deregulated genes, gene mutations, epigenetic modifications, and other …
identification of deregulated genes, gene mutations, epigenetic modifications, and other …